Related Experiment Video
Updated: Mar 6, 2026
10:35
Novel Techniques for Observing Structural Dynamics of Photoresponsive Liquid Crystals
Published on: May 29, 2018
9.3K
Spotlight on Biomimetic Systems Based on Lyotropic Liquid Crystal
Juliana F de Souza1, Katiusca da S Pontes2, Thais F R Alves3
1Laboratory of Biomaterials and Nanotechnology, University of Sorocaba (UNISO), Sorocaba, SP 18078-005, Brazil. julianafsz@yahoo.com.br.
Molecules (Basel, Switzerland)
|March 9, 2017
Summary
Lyotropic liquid crystals (LLCs) show promise for drug delivery due to their tunable structures and biocompatibility. These biomimetic systems offer sustained release and improved bioavailability for various therapeutic applications.
Area of Science:
- Biomaterials Science
- Pharmaceutical Sciences
- Physical Chemistry
Background:
- Lyotropic liquid crystals (LLCs) are self-assembled lipidic nanostructures formed in aqueous media.
- These systems exhibit tunable architectures (lamellar, cubic, hexagonal phases) with unique viscoelastic properties.
- LLCs are biodegradable and biocompatible, minimizing toxicity for diverse administration routes.
Purpose of the Study:
- To review the behavior of lyotropic biomimetic systems in drug delivery.
- To highlight the advantages of LLCs over conventional drug delivery materials.
- To focus on the biomimetic properties of LLCs for enhanced drug delivery.
Main Methods:
- Review of existing literature on lyotropic liquid crystals and their application in drug delivery.
- Analysis of factors influencing drug loading, release, and in vivo interactions.
- Evaluation of LLC properties such as self-assembly, viscoelasticity, and biocompatibility.
Main Results:
- LLC behavior in drug delivery is influenced by drug properties, water content, LLC type, swelling, loading rate, ion effects, and drug-lipid interactions.
- LLCs offer a highly ordered, stable nanostructure suitable for sustained drug release.
- In vivo studies demonstrate the impact of LLC-drug interactions on drug bioavailability.
Conclusions:
- Lyotropic liquid crystals represent a promising biomimetic platform for advanced drug delivery systems.
- Their tunable nature, biocompatibility, and sustained release capabilities offer significant advantages.
- LLCs have the potential to improve therapeutic outcomes through enhanced drug bioavailability and targeted delivery.
Related Concept Videos
01:27Two Components: Liquid–Liquid Systems
34
A pressure-composition phase diagram explicitly describes the behavior of an ideal solution of two volatile liquids under varying pressures and compositions. A pressure-composition diagram has two main curves. The bubble point curve represents the plot of pressure versus liquid mole fraction. It indicates the pressure at which the first bubble of vapor forms from the liquid phase as the system pressure decreases.The dew point curve is the pressure versus vapor mole fraction. It indicates the...
34
01:34The Fluid Mosaic Model
182.2K
The fluid mosaic model was first proposed as a visual representation of research observations. The model comprises the composition and dynamics of membranes and serves as a foundation for future membrane-related studies. The model depicts the structure of the plasma membrane with a variety of components, which include phospholipids, proteins, and carbohydrates. These integral molecules are loosely bound, defining the cell’s border and providing fluidity for optimal function.
182.2K